March 9, 2017—Syncope has many causes and clinical presentations; the incidence depends on the population being evaluated.

September 18, 2016—Drug therapy with beta-blockers represents the therapeutic mainstay for both LQTS and CPVT. The goal of the document is to help clinicians understand the importance of beta-

August 15, 2016—Interoperability is important partly because it facilitates easier extraction of accurate, high-quality data from clinical records.

April 26, 2011—On October 18, 2010, HRS convened the Relationships with Industry Task Force to consider whether it should continue to collaborate with industry, why collab

June 10, 2016—Ventricular cardiomyopathies have been well classified; however, a definition and detailed analysis of atrial cardiomyopathy are lacking from the literature.

February 17, 2016—This consensus statement provides up-to-date clinical practice guidelines for the use of catheter ablation in children 0–18 years of age with any arrhyth

February 1, 2016—The Heart Rhythm Society convened a forum of stakeholders in medical device innovation in conjunction with the 2015 Heart Rhythm Society Annual Scientific Sessions.

December 10, 2015 — The evolution of LAA occlusion technology has spanned nearly two decades and three FDA panel hearings, leading to FDA approval in 2015.

November 19, 2015—The benefits and risks of ICD therapy for patients are directly impacted by the programming and surgical decisions made by the clinician.

September 23, 2015—The purpose of this joint ACC/AHA/HRS document is to provide a contemporary guideline for the management of adults with all types of supraventricular tachycardia (SVT